Keywords: neurocrine, 1st-qtr, loss, down, 1m, usa, biosciences

Neurocrine's 1st-qtr loss down to $21.1M

Article | 12 May 2008

The USA's Neurocrine Biosciences' first-quarter 2008 net loss amounted to $21.1 million, or $0.55 per share, compared with a deficit of $25.7 million, or $0.68 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

GSK

Dainippon Sumitomo Pharma

Go to company listing